About Medtronic Company
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM
ANWAR MEETS WITH GOOGLE, BOEING, MEDTRONIC AND SIEMENS HEALTHINEERS EXECUTIVES IN NEW YORK
Medtronic Obtains CE Mark Approval for Simplera Continuous Glucose Monitor
Medtronic (MDT) said Thursday it has obtained CE Mark approval for its new disposable Simplera continuous glucose monitor. The new glucose monitor integrates with the InPen, a smart insulin pen, that
(Fabrinet surged 21% after its fiscal fourth-quarter results late Monday topped analysts' estimates. The advanced manufacturing services company posted non-GAAP earnings of $1.86 per share, greater than the $1.80 earnings per share expected by analysts polled by FactSet. Revenue came in at $655.9 million, greater than the $641.4 million consensus estimate.)
$Carvana(CVNA.US)$ +16% (Carvana jumped 16% after the online auto retailer reached a deal with noteholders to lower its total debt outstanding by more than $1.2 billion.)
$Nasdaq(NDAQ.US)$ +0.3% (Shares rose 0.3% after Nasdaq topped profit and sales expectations in its second-quarter results. Nasdaq posted adjusted earnings of 71 cents per share on revenue of $925 million. Analysts...